Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays

BACKGROUND: Commercial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests were developed before variants with spike protein mutations emerged, leading to concerns that these tests have reduced sensitivity for detecting antibody responses in individuals infected with Omicron...

Descripción completa

Detalles Bibliográficos
Autores principales: Boler, Michael, Anderson, Mark, Rodgers, Mary, Parumoottil, Jessica, Olivo, Ana, Harris, Barbara, Stec, Michael, Gosha, Amy, Behun, Dylan, Holzmayer, Vera, Anderson, Abby, Greenholt, Ella, Fortney, Tiffany, Almaraz, Eduardo, Cloherty, Gavin, Landay, Alan, Moy, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Coronavirus (COVID-19) Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174724/
https://www.ncbi.nlm.nih.gov/pubmed/37234563
http://dx.doi.org/10.1016/j.ijregi.2023.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174724/
https://www.ncbi.nlm.nih.gov/pubmed/37234563
http://dx.doi.org/10.1016/j.ijregi.2023.04.014

Ejemplares similares